You are here

  • Home
  • Archive
  • Volume 70, Issue 6
  • Haematological cancers: improving outcomes. A summary of updated NICE service guidance in relation to Specialist Integrated Haematological Malignancy Diagnostic Services (SIHMDS)

Article Text

Article menu
Download PDFPDF
Commentary
Haematological cancers: improving outcomes. A summary of updated NICE service guidance in relation to Specialist Integrated Haematological Malignancy Diagnostic Services (SIHMDS)
  1. R J G Cuthbert
  1. Correspondence to Dr R J G Cuthbert, Department of Haematology, Belfast City Hospital, Lisburn Road, Belfast BT24 7WG, UK; robert.cuthbert{at}belfasttrust.hscni.net

https://doi.org/10.1136/jclinpath-2017-204344

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    In modern clinical practice, the diagnosis of haematological malignancies requires the application of a range of laboratory techniques, including morphology, flow cytometry, cytogenetics and molecular pathology. Subsequent disease classification requires correlation with knowledge of the clinical manifestations in individual patients and application of the current WHO classification system, updated in 2016. Employing an integrated approach in this manner can lead to improved accuracy and timeliness of diagnosis, which is highly likely …

    View Full Text

    Footnotes

    • Handling editor Mary Frances McMullin

    • Competing interests None declared.

    • Provenance and peer review Commissioned; internally peer reviewed.

    Linked Articles